PROTAC PD-L1 degrader-2
Product Specifications
Target
PROTACs, MAPK
Related Pathways
MAPK, PROTAC
Bioactivity
PROTAC PD-L1 degrader-2, an orally administered compound, targets HPK1 and boosts the efficacy of PD-L1 antibody therapy.
Molecular Formula
C43H42N8O5
Molecular Weight
750.84
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog